Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement

Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement

Swedish Cancer Institute and Elekta Launch Renewed Partnership Agreement to
Continue the Flow of World-Class Technology, Services to Cancer Patients in the
Pacific Northwest and Beyond

Press Release 
Stockholm, Sweden, May 6, 2010

Swedish Cancer Institute (Seattle) and Elekta recently finalized a strategic
partnership to launch a major new cancer-care initiative to transform radiation
oncology delivery for cancer patients. This unique, multi-year, multi-product
collaboration covers the spectrum of cancer management - from treatment planning
and delivery to workflow and connectivity - and enhances Swedish Cancer
Institute's ability to provide patients access to state-of-the-art technology
early in the product introduction cycle. 

This partnership agreement, which is among the most comprehensive in Elekta's
history, includes Swedish's acquisition of multiple cancer management solutions,
including radiation-therapy treatment systems, treatment planning workstations,
electronic medical record systems, clinical service, and a Leksell Gamma Knife®
Perfexion™ (radiosurgery) system. Elekta will also provide expertise in process
transformation, technology enablement and strategic marketing.

Officials from Swedish and Elekta believe the combination of both organizations'
collective expertise, talents and resources will help deliver transformational
benefits to the Cancer Institute's patient population and solidify the
78-year-old program's reputation as a leading destination for world-class care. 

“When new products role out, they will do so with key input from Swedish Cancer
Institute physicians and our treatment team,” says Jim Yates, administrative
director at Swedish. “This will help make those solutions more
resource-efficient and allow for quicker, smoother integration into the
community cancer center settings.” 
 
Elekta President and CEO Tomas Puusepp says the agreement is mutually beneficial
for both organizations. “Elekta will contribute its innovative technologies and
significant experience in the oncology marketplace to further elevate Swedish's
position as a cancer-care leader. And in turn, Elekta will benefit from the
unique opportunity to partner with one of the most forward-thinking cancer-care
institutions in the United States.”

Elekta's Jim Rose, Vice President of Comprehensive Oncology Solutions, adds that
the partnership is a natural fit because both parties have closely aligned
missions and values when it comes to improving human care. 

“We both strongly believe that a world-class center of excellence requires
world-class providers who work tirelessly to ensure that state-of-the-art
technology delivers ever-increasing benefits to patients,” Rose says.

Swedish Cancer Institute has a long history of early adoption of radiation
treatment technology. Through its Center for Advanced Targeted Radiotherapies
(CATRT), Swedish Cancer Institute works collaboratively with technology partners
to optimize clinical tools and practices early in the innovation cycle.

“Our position as a leading, non-profit health-care provider means we have an
obligation to explore new solutions that contribute to making health-care
delivery more efficient and effective. Embarking on this type of partnership
with Elekta, the major provider of radiation oncology technology, will allow us
to help steer the future of technology and its integration into community cancer
centers,” says Swedish CEO Dr. Rod Hochman.

“Swedish Cancer Institute continues to build on its track record for radiation
oncology innovation and excellent patient care. This unprecedented partnership
will allow Elekta's development engineers to have access to clinical radiation
oncology experts and should result in a better, more improved product,” says
Vivek Mehta, M.D., director of the CATRT at Swedish Cancer Institute.

Elekta will also deploy its technology and strategy experts alongside Swedish
Cancer Institute's key physicians, clinicians and administrators to ensure the
highest priority is placed on implementing successive phases of the agreement.

In addition, the partnership includes establishment of Swedish Cancer Institute
as a customer training facility, clinical product development center, and global
reference site for Elekta.

###

For further information, please contact:
Stina Thorman, Vice President Corporate Communications, Elekta AB
Tel: +46 8 587 254 37, email: stina.thorman@elekta.com
Time zone: CET: Central European

Michelle Lee, Director, Global Public Relations and Brand Management, Elekta
Tel: +1 770-670-2447, email: michelle.lee@elekta.com
Time zone: EDT: Eastern Daylight

Ed Boyle, Media Relations Manger, Swedish and Swedish Cancer Institute
Tel: +1 206-386-2748, e-mail: ed.boyle@swedish.org 
Time zone: PST (Pacific Standard)

About Elekta 
Elekta is a human-care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment-planning systems for
radiation therapy and radiosurgery, as well as workflow-enhancing software
systems across the spectrum of cancer care. 
Stretching the boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both health-care providers
and patients, Elekta aims to improve, prolong and even save patient lives,
making the future possible today. 
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000
hospitals globally, and every day more than 100,000 patients receive diagnosis,
treatment or follow-up with the help of a solution from the Elekta Group. 
Elekta employs around 2,500 employees globally. The corporate headquarter is
located in Stockholm, Sweden, and the company is listed on the Nordic Exchange
under the ticker EKTAb. For more information about Elekta, visit www.elekta.com.

About Swedish
Established in 1910, Swedish has grown to become the largest, most comprehensive
non-profit health provider in the Greater Seattle area over its 100-year
history. Today, it is comprised of three hospital campuses - First Hill, Cherry
Hill and Ballard - a freestanding emergency department and ambulatory care
center in Issaquah, Swedish Visiting Nurse Services, the Swedish Physician
Division - a network of more than 40 primary-care and specialty clinics located
throughout the Puget Sound area. This fall, Swedish broke ground on a new
medical office building and hospital in the Issaquah Highlands, as well as a new
emergency department and medical office building in Ballard. In addition to
general medical and surgical care, Swedish is known as a regional referral
center, providing specialized treatment in areas such as cancer care,
neuroscience, cardiovascular care, orthopedics, high-risk obstetrics, pediatric
specialties, general and robotic-assisted surgery, organ transplantation and
clinical research. For more information, visit www.swedish.org and
www.swedish100.org.

About Swedish Cancer Institute
Swedish Cancer Institute (SCI) opened in 1932 as the first dedicated cancer-care
center west of the Mississippi River. Since then, it has grown to become the
largest, most comprehensive cancer treatment program in the Pacific Northwest.
The Institute has a presence on all three of Swedish's hospital campuses as well
as in East King County through a medical oncology clinic near Issaquah. A true
multidisciplinary program, SCI offers a wide range of advanced cancer-treatment
options in chemotherapy, radiation therapy and surgery - backed by extensive
diagnostic capabilities, patient education and support-group services. The
Institute's clinical-research arm includes industry-sponsored and cooperative
group therapeutic trials, cancer screening and prevention trials, and
investigator-initiated trials. Breast-cancer screening and diagnostics are
available through the Swedish Breast Care Centers and two state-of-the-art
mobile mammography coaches. Swedish radiation therapy is also offered at various
Puget Sound-area community hospitals including Stevens Hospital (Edmonds),
Valley Medical Center (Renton), Highline Community Hospital (Burien), and
Northwest Hospital (North Seattle). For more information, visit www.swedish.org

About SCI's Center for Advanced Targeted Radiotherapies
SCI's Center for Advanced Targeted Radiotherapies encompasses the comprehensive
and complementary array of advanced and emerging radiation delivery tools
available to patients for both approved therapies and clinical-research efforts.
That includes technologies such as Intensity-Modulated Radiation Therapy,
Image-Guided Radiation Therapy, linear accelerator-based stereotactic
radiosurgery, the Calypso® 4D Localization System, Xoft Axxent™ Electronic
Brachytherapy System, MammoSite® Radiation Therapy System, and the Seattle
CyberKnife Center™ at Swedish. SCI is also working toward adding the latest
generation of proton beam radiotherapy systems.